Atria Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,623
Closed -$271K 2120
2025
Q2
$271K Sell
10,623
-459
-4% -$10K ﹤0.01% 1768
2025
Q1
$237K Sell
11,082
-906
-8% -$20.2K ﹤0.01% 1747
2024
Q4
$252K Sell
11,988
-590
-5% -$13.7K ﹤0.01% 1679
2024
Q3
$283K Sell
12,578
-25,588
-67% -$494K ﹤0.01% 1641
2024
Q2
$640K Buy
+38,166
New +$613K 0.01% 1182

Other funds holding PAHC

Atria Investments's PAHC Position: Q3 2025 in Review

Atria Investments sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 10,623 shares — an estimated $271K sold.

Atria Investments first reported a position in PAHC in Q2 2024 and held it in 5 quarters. The position peaked at $640K in Q2 2024. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Atria Investments reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Atria Investments sold 10,623 Phibro Animal Health shares in Q3 2025, an estimated $271K.
  • Atria Investments first reported a position in Phibro Animal Health in Q2 2024 and held it in 5 quarters.
  • Atria Investments's Phibro Animal Health position peaked at $640K in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Atria Investments's 13F filing for Q3 2025, filed 6 Nov 2025.